ODDB.org: Open Drug Database

Roche Pharma (Schweiz) AG - Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	58868	Sequence	03
Product name	Actemra 400 mg/20 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L04AC07	ATC-Description	Tocilizumab
Introduction of Sequence	02.12.2008

Composition

tocilizumabum 400 mg, polysorbatum 80, saccharum, dinatrii phosphas dodecahydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 8.84 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Tocilizumabum	400mg / 20ml

BAG: Active Agent	Dose
Tocilizumabum	400 mg

Inactive agents
Disodium Phosphate Dodecahydrate
Sodium Dihydrogenophosphate Dihydrate
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	Durchstechflasche(n)	648.78	722.00	A	SL	No

2025	©ywesee GmbH